Maurer, M., Altrichter, S., Bieber, T., Biedermann, T., Bräutigam, M., Seyfried, S., . . . Staubach, P. (2011). Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase. The journal of allergy and clinical immunology, 128(1), . https://doi.org/10.1016/j.jaci.2011.04.038
Chicago-Zitierstil (17. Ausg.)Maurer, Marcus, et al. "Efficacy and Safety of Omalizumab in Patients with Chronic Urticaria Who Exhibit IgE Against Thyroperoxidase." The Journal of Allergy and Clinical Immunology 128, no. 1 (2011). https://doi.org/10.1016/j.jaci.2011.04.038.
MLA-Zitierstil (9. Ausg.)Maurer, Marcus, et al. "Efficacy and Safety of Omalizumab in Patients with Chronic Urticaria Who Exhibit IgE Against Thyroperoxidase." The Journal of Allergy and Clinical Immunology, vol. 128, no. 1, 2011, https://doi.org/10.1016/j.jaci.2011.04.038.